Verified peer comparison
Recursion Pharmaceuticals, Inc. - Class A Common Stock vs AbCellera Biologics Inc. - Common Shares Financial Comparison
Recursion Pharmaceuticals, Inc. - Class A Common Stock versus AbCellera Biologi…
Direct answer
Recursion Pharmaceuticals, Inc. - Class A Common Stock and AbCellera Biologics Inc. - Common Shares are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Recursion Pharmaceuticals, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Recursion Pharmaceuticals, Inc. - Class A Common Stock Revenue
- 74,681,000 USD
- AbCellera Biologics Inc. - Common Shares Revenue
- 75,128,000 USD
- Recursion Pharmaceuticals, Inc. - Class A Common Stock Operating income
- -648,132,000 USD
- AbCellera Biologics Inc. - Common Shares Operating income
- -217,103,000 USD